Performance of Sokolow-Lyon index in detection of echocardiographically diagnosed left ventricular hypertrophy in a normal Eastern German population - results of the CARLA study

Table 2 Linear regression of echocardiographic parameters on the Sokolow-Lyon index

	Crude beta^a (95 % CI)	p	Adjusted beta^a,b (95 % CI)	p
LVMI (g/m²)	4.19 (1.40–6.99)	0.0033	7.02 (4.49–9.54)	<0.0001
LVIDd (cm/m²)	0.10 (0.08–0.12)	<0.0001	0.06 (0.04–0.08)	<0.0001
PWTd (cm)	−0.01 (−0.02–0.00)	0.1533	0.01 (0.00–0.02)	0.1078
SWTd (cm)	−0.01 (−0.02–0.00)	0.1435	0.01 (0.00–0.02)	0.0927
Dichotomized outcome for impaired echocardiographic LVH parameters [13] (odds ratios)
LVMI	1.37 (0.67–2.79)	0.3892	1.59 (0.74–3.42)	0.233
LVIDd	1.93 (0.81–4.61)	0.1379	1.24 (0.48–3.16)	0.6572
PWTd	2 (0.48–8.29)	0.341	2.62 (0.59–11.59)	0.2041
SWTd	2.25 (0.54–9.32)	0.2633	2.66 (0.6–11.81)	0.1993

SLI Sokolow-Lyon index, LVMI left ventricular mass index, LVIDd left-ventricular internal diameter at end-diastole index, PWTd left-ventricular posterior wall thickness at end-diastole, SWTd septal wall thickness at end-diastole, 95 % CI 95 % confidence interval
^aadjusted for sex, sport index, smoking status, NT-pro BNP, low density lipoprotein, arterial hypertension, waist-to-hip ratio, diabetes mellitus, regular intake of antiarrhythmic medication, beta blockers and digitalis glycosides
^bBeta gives the increase of the respective echocardiographic parameter per mV increase of the SLI

ISSN: 1471-2261